Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Update

Key Points

• Short interest plunged 98.0% to 390 shares as of March 31 from 19,458 on March 15, leaving a days-to-cover of 0.0 and approximately 0.0% of shares shorted.
• Straumann traded up 0.2% to $10.60 on Friday with volume of 72,750 (versus average volume of 219,001) and is trading below its 50‑day and 200‑day moving averages (~$11.23 and $11.56).
• Analysts are broadly negative: one Buy, two Hold and two Sell produce a MarketBeat consensus rating of "Reduce", with Morgan Stanley and Citigroup reiterating underweight/sell calls.

Straumann Holding AG (OTCMKTS:SAUHY - Get Free Report) was the recipient of a significant decline in short interest in the month of March. As of March 31st, there was short interest totaling 390 shares, a decline of 98.0% from the March 15th total of 19,458 shares. Based on an average daily volume of 665,091 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold.

Straumann Trading Up 0.2%

OTCMKTS:SAUHY traded up $0.02 during trading hours on Friday, reaching $10.60. The company had a trading volume of 72,750 shares, compared to its average volume of 219,001. Straumann has a 1-year low of $9.44 and a 1-year high of $14.18. The business's 50 day moving average price is $11.23 and its 200-day moving average price is $11.56.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Morgan Stanley reiterated an "underweight" rating on shares of Straumann in a report on Monday, December 15th. Citigroup reaffirmed a "sell" rating on shares of Straumann in a report on Wednesday, January 14th. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Reduce".

About Straumann

Straumann OTCMKTS: SAUHY is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company's core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.